Validation of the Edinburgh postnatal depression scale (EPDS) for screening of major depressive episode among adults from the general population
Carregando...
Citações na Scopus
82
Tipo de produção
article
Data de publicação
2014
Editora
BIOMED CENTRAL LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
MUNHOZ, Tiago N.
TAVARES, Beatriz Franck
BARBOSA, Ana Paula Pereira Neto
SILVA, Diego Mello da
ABITANTE, Morgana Sonza
DALL'AGNOL, Tatiane Abreu
SANTOS, Ina S.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
BMC PSYCHIATRY, v.14, article ID 284, 9p, 2014
Resumo
Background: Standardized questionnaires designed for the identification of depression are useful for monitoring individual as well as population mental health. The Edinburgh Postnatal Depression Scale (EPDS) has originally been developed to assist primary care health professionals to detect postnatal depression, but several authors recommend its use outside of the postpartum period. In Brazil, the use of the EPDS for screening depression outside the postpartum period and among non-selected populations has not been validated. The present study aimed to assess the validity of the EPDS as a screening instrument for major depressive episode (MDE) among adults from the general population. Methods: This is a validation study that used a population-based sampling technique to select the participants. The study was conducted in the city of Pelotas, Brazil. Households were randomly selected by two stage conglomerates with probability proportional to size. EPDS was administered to 447 adults (>= 20 years). Approximately 17 days later, participants were reinterviewed by psychiatrics and psychologists using a structured diagnostic interview (Mini International Neuropsychiatric Interview, MINI). We calculated the sensitivity and specificity of each cutoff point of EPDS, and values were plotted as a receiver operator characteristic curve. Results: The best cutoff point for screening depression was >= 8, with 80.0% (64.4 - 90.9%) sensitivity and 87.0% (83.3 - 90.1%) specificity. Among women the best cutoff point was >= 8 too with values of sensitivity and specificity of 84.4% (67.2 - 94.7%) and 81.3% (75.5 - 86.1%), respectively. Among men, the best cutoff point was >= 7 (75% sensitivity and 89% specificity). Conclusions: The EPDS was shown to be suitable for screening MDE among adults in the community.
Palavras-chave
Major depressive episode, Validity of tests, Sensitivity and specificity, Adult, EPDS test, Depression
Referências
- Alonso J, 2008, ACTA PSYCHIAT SCAND, V118, P305, DOI 10.1111/j.1600-0447.2008.01241.x
- Areias MEG, 1996, BRIT J PSYCHIAT, V169, P30, DOI 10.1192/bjp.169.1.30
- Aydin N, 2004, SOC PSYCH PSYCH EPID, V39, P483, DOI 10.1007/s00127-004-0770-4
- Becht MC, 2001, J AFFECT DISORDERS, V63, P209, DOI 10.1016/S0165-0327(99)00189-5
- Benvenuti P, 1999, J AFFECT DISORDERS, V53, P137, DOI 10.1016/S0165-0327(98)00102-5
- Berle JO, 2003, J AFFECT DISORDERS, V76, P151, DOI 10.1016/S0165-0327(02)00082-4
- Boing AF, 2012, REV SAUDE PUBL, V46, P617, DOI http://dx.doi.org/10.1590/s0034-89102012000400005
- Castelo MS, 2010, INT PSYCHOGERIATR, V22, P109, DOI 10.1017/S1041610209991219
- Cox JL, 1996, J AFFECT DISORDERS, V39, P185, DOI 10.1016/0165-0327(96)00008-0
- COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782
- Da-Silva VA, 1998, BRAZ J MED BIOL RES, V31, P799, DOI 10.1590/S0100-879X1998000600012
- Eberhard-Gran M, 2001, ACTA PSYCHIAT SCAND, V104, P243, DOI 10.1034/j.1600-0447.2001.00187.x
- Edmondson OJH, 2010, J AFFECT DISORDERS, V125, P365, DOI 10.1016/j.jad.2010.01.069
- Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547
- Figueira Patrícia, 2009, Rev Saude Publica, V43 Suppl 1, P79
- Gabilondo A, 2012, GEN HOSP PSYCHIAT, V34, P510, DOI 10.1016/j.genhosppsych.2012.05.005
- Garcia-Esteve L, 2003, J AFFECT DISORDERS, V75, P71, DOI 10.1016/S0165-0327(02)00020-4
- Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x
- Goetzel RZ, 2012, HEALTH AFFAIR, V31, P2474, DOI 10.1377/hlthaff.2011.0819
- Halbreich U, 2006, J AFFECT DISORDERS, V91, P97, DOI 10.1016/j.jad.2005.12.051
- Kessler RC, 2010, DEPRESS ANXIETY, V27, P351, DOI 10.1002/da.20634
- Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23
- Lai BPY, 2010, PSYCHIAT RES, V180, P80, DOI 10.1016/j.psychres.2009.07.015
- Lloyd-Williams M, 2000, J PAIN SYMPTOM MANAG, V20, P259, DOI 10.1016/S0885-3924(00)00182-2
- Marques JMD, 2008, GEN HOSP PSYCHIAT, V30, P303, DOI 10.1016/j.genhosppsych.2008.02.001
- Matthey S, 2001, J AFFECT DISORDERS, V64, P175, DOI 10.1016/S0165-0327(00)00236-6
- Meyer Christian, 2004, Evid Based Ment Health, V7, P123
- Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
- MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288
- Pitanupong J, 2007, PSYCHIAT RES, V149, P253, DOI 10.1016/j.psychres.2005.12.011
- Santos IS, 2007, CAD SAUDE PUBLICA, V23, P2577, DOI 10.1590/S0102-311X2007001100005
- Santos IS, 2013, CAD SAUDE PUBLICA, V29, P1533, DOI 10.1590/0102-311X00144612
- Santos MFS, 1999, REV PSIQUIATR CLIN, V26, P90
- Sartorius N, 2007, LANCET, V370, P810, DOI 10.1016/S0140-6736(07)61245-8
- Schulze B, 2009, LANCET, V373, P362, DOI 10.1016/S0140-6736(08)61818-8
- Silva MT, 2014, REV BRAS PSIQUIATR, V36, P262, DOI 10.1590/1516-4446-2013-1294
- Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208
- Thorpe K., 1993, J REPROD INFANT PSYC, V11, P119, DOI 10.1080/02646839308403204
- Vivilaki VG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-329
- Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048